Emilie Sbidian (Émilie Sbidian, E Sbidian)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 50

Top Topics

Health Insurance

Top Venues

The British journal of dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

Arthritis & rheumatology (Hoboken, N.J.)

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Lea Hoisnard, Antoine Meyer, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik, Emilie Sbidian
Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study. Arthritis & rheumatology (Hoboken, N.J.) 76 (9) (2024)
Lea Hoisnard, Antoine Meyer, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik, Emilie Sbidian
Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Lea Hoisnard, Antoine Meyer, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik, Emilie Sbidian
Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study. Arthritis & rheumatology (Hoboken, N.J.) 76 (9) (2024)
R Ouakrat, B Peiffer, J P David, T Belmondo, Emilie Sbidian, F Canouï-Poitrine, Saskia Ingen Housz Oro
Functional decline among bullous pemphigoid patients: A retrospective monocentric cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Lea Hoisnard, Antoine Meyer, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik, Emilie Sbidian
Risk of gastrointestinal perforation in patients with rheumatic diseases exposed to janus kinase inhibitors versus adalimumab: nationwide cohort study. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Christophe Bontoux, Marine Badrignans, Sivem Afach, Emilie Sbidian, Diana-Laure Mboumba, Saskia Ingen Housz Oro, Alexis Claudel, Marie-Hélène Aubriot-Lorton, Arnaud Chong-Si-Tsaon, Gilles Le Masson, Christophe Attencourt, Romain Dubois, Fanny Beltzung, Wafa Koubaa, Helmut Beltraminelli, Nathalie Cardot-Leccia, Brigitte Balme, Anh Tuan Nguyen, Kelly Bagny, Delphine Legoupil, Ibtissam Moustaghfir, Juliette Denamps, Laurent Mortier, Houda Hammami-Ghorbel, Sergey Skrek, Mostefa Rafaa, Anne-Claire Fougerousse, Thibaut Deschamps, Stéphane Dalle, Michel D'incan, Guillaume Chaby, Marie Beylot-Barry, Sophie Dalac, Nicolas Ortonne
Pustular mycosis fungoides has a poor outcome: a multicentric clinico-pathological and molecular case series study. The British journal of dermatology (2024)
Thomas Bettuzzi, Anne Welfringer-Morin, Saskia Ingen Housz Oro, Pauline Bataille, Bénédicte Lebrun-Vignes, Christine Bodemer, Emilie Sbidian
Comparison of incidence, causes and prognosis of adult and pediatric epidermal necrolysis: a population-based study in France. The British journal of dermatology (2024)
Saskia Ingen Housz Oro, Pascal Joly, Willy Kini-Matondo, Emilie Sbidian
Prevention of recurrent erythema multiforme with lenalidomide: a case series. Clinical and experimental dermatology (2023)
Hugo Jourdain, Lea Hoisnard, Emilie Sbidian, Mahmoud Zureik
Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Clarisse Marcombes, Laetitia Penso, Alain Weill, Rosemary Dray-Spira, Mahmoud Zureik, Emilie Sbidian
Persistence of second-line biologics in psoriasis after first-line biologic failure: a nationwide cohort study from the French health insurance database (SNDS). The British journal of dermatology (2023)
Hélène Aubert, Hugo Arlegui, Yann De Rycke, Herve Bachelez, Marie Beylot-Barry, Alain Dupuy, Pascal Joly, Denis Jullien, Emmanuel Mahé, Carle F Paul, Marie-Aleth Richard, Emilie Sbidian, Manuelle Viguier, Olivier Chosidow, Florence Tubach, Nathalie Bénéton, null null
Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq Registry. The British journal of dermatology 188 (1) (2023)
Emilie Sbidian
A multistep approach from scoping review to strong evidence: biomarkers in psoriasis. The British journal of dermatology (2023)
Romain Salle, Florence Tubach, Hugo Arlegui, Raphaëlle Curmin, Manuelle Viguier, Marie Beylot-Barry, Alain Dupuy, Nathalie Beneton, Pascal Joly, Yann De Rycke, Denis Jullien, Emmanuel Mahé, Carle F Paul, Marie-Aleth Richard, Herve Bachelez, Marilyn Zago, Olivier Chosidow, Emilie Sbidian, null null
Clinical features, therapeutic choice and response by phototype in psoriasis: analysis of the French PsoBioTeq cohort. Clinical and experimental dermatology (2023)
Chloé Grolleau, Laurence Le Cleach, Jason Shourick, Emilie Sbidian, Sivem Afach
Long-term clinical trials of biologics in plaque psoriasis demonstrate heterogeneous study designs. The British journal of dermatology (2023)
Parna Moghadam, Karine Billard, Sophie Lalevée, Damien Motavasseli, Emilie Sbidian, Nicolas De Prost, Jacques Pariat, Saskia Ingen Housz Oro
Heterotopic ossification: An unusual sequela of toxic epidermal necrolysis. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Florence Assan, B Husson, S Hegazy, Julien Seneschal, F Aubin, Emmanuel Mahé, Denis Jullien, Emilie Sbidian, M D'Incan, Curdin Conrad, Emilie Brenaut, C Girard, Marie Aleth Richard, H Bachelez, M Viguier, null null
Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (9) (2022)
R Curmin, S Guillo, Y De Rycke, H Bachelez, Marie Beylot-Barry, N Beneton, Olivier Chosidow, A Dupuy, Pascal Joly, Denis Jullien, Marie Aleth Richard, M Viguier, Emilie Sbidian, C Paul, Emmanuel Mahé, F Tubach, null null
Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQ. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (11) (2022)
Christina Bergqvist, L Fertitta, Khaled Ezzedine, A Jannic, O Zehou, S Ferkal, P Combemale, Sébastien Barbarot, Mazereeuw-Hautier Juliette, Emilie Sbidian, P Wolkenstein, null null
Identification of three clinical neurofibromatosis 1 subtypes: Latent class analysis of a series of 1351 patients. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (5) (2022)
Pauline Bataille, Richard Layese, Pascal Claudepierre, Nicolas Paris, Julien Dubiel, Aurélien Amiot, Emilie Sbidian, null null
Paradoxical reactions and biologic agents: a French cohort study of 9303 patients. The British journal of dermatology 187 (5) (2022)
Lea Hoisnard, Laura Pina Vegas, Rosemay Dray-Spira, Alain Weill, Mahmoud Zureik, Emilie Sbidian
Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study. Annals of the rheumatic diseases (2022)
Robin Guelimi, Silvia Metelli, Emilie Sbidian, Esther J van Zuuren, Carsten Flohr, Jo Leonardi-Bee, Laurence Le Cleach
Network meta-analysis: methodological points for readers, authors and reviewers. The British journal of dermatology 186 (6) (2022)
Emilie Sbidian, L Pina-Vegas
Head-to-head trials in psoriasis and psoriatic arthritis: how to conclude? The British journal of dermatology (2021)
Robin Guelimi, R Salle, L Dousset, H Assier, S Fourati, Z Bhujoo, Sébastien Barbarot, C Boulard, C Cazanave, A Colin, E Kostrzewa, Cécile Lesort, A Levy Roy, F Lombart, J Marco Bonnet, L Marty, Jean-Benoît Monfort, L Riffaud, M Samimi, M Tardieu, Emilie Sbidian, P Wolkenstein, L Le Cleach, Marie Beylot-Barry
Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (9) (2021)
Antoine Bertolotti, Emilie Sbidian, O Join-Lambert, I Bourgault-Villada, M Moyal-Barracco, P Perrot, N Jouan, Y Yordanov, S Sidorkiewicz, K Chazelas, M-F Bru-Daprés, E Caumes, J-F Sei, null null, Olivier Chosidow, Marie Beylot-Barry, null null
Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology. The British journal of dermatology 184 (5) (2021)
Emilie Sbidian, Laëtitia Penso, Antoine Meyer
Reply: comment on: Risk of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis initiating interleukin 17 inhibitors. Arthritis & rheumatology (Hoboken, N.J.) (2021)
Marie Beylot-Barry, Julien Seneschal, D Tran, Herve Bachelez, N Beneton, A Dupuy, P Joly, Denis Jullien, Emmanuel Mahé, Carle F Paul, Marie Aleth Richard, Emilie Sbidian, M Viguier, Olivier Chosidow, F Tubach
Characteristics of patients with psoriasis with Psoriasis Area and Severity Index < 10 treated with biological agents: results from the French PsoBioTeq cohort. The British journal of dermatology 185 (5) (2021)
L Penso, R Dray-Spira, A Weill, M Zureik, Emilie Sbidian
Drop in biological initiation for patients with psoriasis during the COVID-19 pandemic. The British journal of dermatology 185 (3) (2021)
Laëtitia Penso, Christina Bergqvist, Antoine Meyer, Philippe Herlemont, Alain Weill, Mahmoud Zureik, Rosemary Dray-Spira, Emilie Sbidian
Risk of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis initiating interleukin 17 inhibitors: a nationwide population-based study using the French national health data system. Arthritis & rheumatology (Hoboken, N.J.) (2021)
L Penso, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik, Emilie Sbidian
Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France. The British journal of dermatology (2021)
G Obeid, G Do, L Kirby, C Hughes, Emilie Sbidian, Laurence Le Cleach
Interventions for chronic palmoplantar pustulosis: abridged Cochrane systematic review and GRADE assessments. The British journal of dermatology 184 (6) (2020)
Sivem Afach, Anna Chaimani, T Evrenoglou, L Penso, E Brouste, Emilie Sbidian, Laurence Le Cleach
Meta-analysis results do not reflect the real safety of biologics in psoriasis. The British journal of dermatology 184 (3) (2020)
Camille Grodner, M Mezzarobba, A Weill, Emilie Sbidian
Evolution of topical steroids consumption before and after initiation of systemic treatment in psoriasis: epidemiologic study in a real-world analysis of the French national health insurance database. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (6) (2020)
Laurence Le Cleach, L Dousset, Haudrey Assier, S Fourati, Sébastien Barbarot, C Boulard, C Bourseau Quetier, L Cambon, C Cazanave, A Colin, E Kostrzewa, C Lesort, A Levy Roy, F Lombart, J Marco-Bonnet, Jean-Benoît Monfort, Mahtab Samimi, M Tardieu, P Wolkenstein, Emilie Sbidian, Marie Beylot-Barry, null null
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing. The British journal of dermatology 183 (5) (2020)
Emilie Sbidian, Laetitia Penso, Philippe Herlemont, Jérémie Botton, Bérangère Baricault, Laura Semenzato, Jérome Drouin, Alain Weill, Rosemay Dray-Spira, Mahmoud Zureik
Comment on 'Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19' by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France. Annals of the rheumatic diseases (2020)
Laurence Le Cleach, S Fourati, Emilie Sbidian, Marie Beylot-Barry
Negative tests for SARS-CoV-2 infection do not rule out its responsibility for chilblains: reply from the authors. The British journal of dermatology 183 (6) (2020)
C Charpentier, F Kouby, C Hua, Emilie Sbidian, M Darty, R Bosc, N De Prost, C Gomart, P-L Woerther, A Tazi, J-W Decousser, Olivier Chosidow, null null
Group B streptococcal necrotizing soft-tissue infection: role of pharyngeal and perineal carriage. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (3) (2020)
Emilie Sbidian, M Madrange, M Viguier, M Salmona, S Duchatelet, A Hovnanian, A Smahi, J Le Goff, Herve Bachelez
Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds. The British journal of dermatology 181 (6) (2019)
Christophe Rodriguez, A Jary, C Hua, P-L Woerther, R Bosc, M Desroches, E Sitterlé, G Gricourt, Nicolas De Prost, J-M Pawlotsky, Olivier Chosidow, Emilie Sbidian, J-W Decousser, null null
Pathogen identification by shotgun metagenomics of patients with necrotizing soft-tissue infections. The British journal of dermatology 183 (1) (2019)
Ignacio García Doval, Emilie Sbidian
Effectiveness of classic drugs in psoriasis: still alive. The British journal of dermatology 181 (2) (2019)
Thomas Bettuzzi, L Penso, Nicolas De Prost, F Hemery, C Hua, A Colin, A Mekontso-Dessap, Laurence Fardet, O Chosidow, P Wolkenstein, Emilie Sbidian, Saskia Ingen Housz Oro
Trends in mortality rates for Stevens-Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017. The British journal of dermatology 182 (1) (2019)
C Prouteau, M Dinulescu, E Oger, C Pruvost-Balland, S Buche, O Cogrel, M Delage, Annabel Maruani, I Nicol, Emilie Sbidian, A P Villani, M Viguier, M Chastagner, C Grodner, J Kaoutar, C Laurent, Sophie Leducq, A Dupuy, Catherine Droitcourt, null null
Concordance of severity scores for photographic assessment of hidradenitis suppurativa. The British journal of dermatology 182 (2) (2019)
Emilie Sbidian, L Le Cleach
'COre SUBgroup SETs (COSUBSET)' initiative is needed. The British journal of dermatology 182 (4) (2019)
Christina Bergqvist, M Mezzarobba, A Weill, Emilie Sbidian
Persistence of treatment with conventional systemic agents for patients with psoriasis: a real-world analysis of 73 168 new users from the French National Health Insurance database. The British journal of dermatology 182 (6) (2019)
C Traikia, C Hua, L Le Cleach, Nicolas De Prost, F Hemery, Thomas Bettuzzi, O Chosidow, P Wolkenstein, Saskia Ingen Housz Oro, Emilie Sbidian
Individual- and hospital-level factors associated with epidermal necrolysis mortality: a nationwide multilevel study, France, 2012-2016. The British journal of dermatology 182 (4) (2019)
J Gottlieb, M Madrange, C Gardair, Emilie Sbidian, A Frazier, P Wolkenstein, G Hickman, P Schneider, C Baudry, P Claudepierre, P Bertheau, P Richette, A Smahi, Herve Bachelez
PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens. The British journal of dermatology 181 (4) (2019)
Emilie Sbidian, C Billionnet, A Weill, G Maura, M Mezzarobba
Persistence of apremilast in moderate-to-severe psoriasis: a real-world analysis of 14 147 apremilast- and methotrexate-naive patients in the French National Health Insurance database. The British journal of dermatology 182 (3) (2019)
Emilie Sbidian, M Mezzarobba, A Weill, J Coste, J Rudant
Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16 545 biologic-naïve patients from the French National Health Insurance database (SNIIRAM). The British journal of dermatology 180 (1) (2018)
M Larsabal, S Ly, Emilie Sbidian, M Moyal-Barracco, J-N Dauendorffer, N Dupin, M A Richard, O Chosidow, Marie Beylot-Barry
GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis. The British journal of dermatology 180 (3) (2018)
L Hefez, K Zaghbib, Emilie Sbidian, L Valeyrie-Allanore, M Allain, T A Duong, A Colin, F Bellivier, H Romano, Nicolas De Prost, K Chazelas, O Chosidow, P Wolkenstein, S Ingen-Housz-Oro
Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients. The British journal of dermatology 180 (5) (2018)
J Gottlieb, S Ingen-Housz-Oro, M Alexandre, S Grootenboer-Mignot, F Aucouturier, Emilie Sbidian, E Tancrede, P Schneider, E Regnier, C Picard-Dahan, E Begon, C Pauwels, K Cury, S Hüe, C Bernardeschi, N Ortonne, F Caux, P Wolkenstein, O Chosidow, Catherine Prost-Squarcioni
Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults. The British journal of dermatology 177 (1) (2017)